Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-13 Sale |
2021-05-14 8:35 pm |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
100,000 | $25.38 | $2,538,000 | 778,958 (Indirect Direct) |
View |
| 2021-04-26 Sale |
2021-04-28 8:10 pm |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
50,000 | $25 | $1,250,000 | 628,362 (Indirect Direct) |
View |
| 2021-04-01 Sale |
2021-04-02 7:41 pm |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
50,000 | $23 | $1,150,000 | 678,362 (Indirect Direct) |
View |
| 2021-02-17 Sale |
2021-02-19 7:57 pm |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
100,000 | $22.43 | $2,242,500 | 805,477 (Indirect Direct) |
View |
| 2020-06-04 Sale |
2020-06-05 8:00 pm |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
100,000 | $22.96 | $2,296,000 | 540,843 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-07-26 Exercise |
2021-07-28 8:06 pm |
2017-02-11 2023-02-10 |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
40,000 | $0 | 703,958 (Direct) |
View |
| 2021-07-26 Exercise |
2021-07-28 8:06 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
40,000 | $4.2 | 703,958 (Direct) |
View |
| 2021-07-21 Exercise |
2021-07-23 7:47 pm |
2017-02-11 2023-02-10 |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
35,000 | $0 | 703,958 (Direct) |
View |
| 2021-07-21 Exercise |
2021-07-23 7:47 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
35,000 | $4.2 | 703,958 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 11:59 am |
2022-07-01 2031-07-01 |
GENOCEA BIOSCIENCES INC. | GNCA | Schwab Gisela Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-05-13 Exercise |
2021-05-14 8:35 pm |
2015-07-20 2022-02-04 |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
100,000 | $0 | 778,958 (Direct) |
View |
| 2021-05-13 Exercise |
2021-05-14 8:35 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
100,000 | $1.9 | 778,958 (Direct) |
View |
| 2021-04-26 Exercise |
2021-04-28 8:10 pm |
2015-07-20 2021-09-18 |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
50,000 | $0 | 628,362 (Direct) |
View |
| 2021-04-26 Exercise |
2021-04-28 8:10 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
50,000 | $1.7 | 628,362 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-02 7:41 pm |
2015-07-20 2021-09-18 |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
50,000 | $0 | 678,362 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-02 7:41 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
50,000 | $1.7 | 678,362 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-05 8:03 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
72,885 | $0 | 628,362 (Direct) |
View |
| 2021-02-17 Exercise |
2021-02-19 7:57 pm |
2015-07-20 2021-09-18 |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
100,000 | $0 | 805,477 (Direct) |
View |
| 2021-02-17 Exercise |
2021-02-19 7:57 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
100,000 | $1.7 | 805,477 (Direct) |
View |
| 2021-02-15 Tax Withholding |
2021-02-17 8:10 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
2,858 | $21.91 | 555,477 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 9:16 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
81,038 | $0 | 558,335 (Direct) |
View |
| 2021-02-03 Tax Withholding |
2021-02-05 9:16 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
14,982 | $22.56 | 558,335 (Direct) |
View |
| 2020-11-15 Tax Withholding |
2020-11-17 7:57 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
14,953 | $20.16 | 492,279 (Direct) |
View |
| 2020-10-22 Option Award |
2020-10-26 8:11 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
213,879 | $0 | 506,715 (Direct) |
View |
| 2020-10-22 Tax Withholding |
2020-10-26 8:11 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
55,235 | $21.79 | 506,715 (Direct) |
View |
| 2020-09-02 Option Award |
2020-09-04 6:32 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
9,745 | $0 | 348,071 (Direct) |
View |
| 2020-09-02 Tax Withholding |
2020-09-04 6:32 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
2,517 | $21.58 | 348,071 (Direct) |
View |
| 2020-06-04 Exercise |
2020-06-05 8:00 pm |
2015-07-20 2021-09-18 |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
100,000 | $0 | 540,843 (Direct) |
View |
| 2020-06-04 Exercise |
2020-06-05 8:00 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
100,000 | $1.7 | 540,843 (Direct) |
View |